imatinib mesylate has been researched along with Blood Loss, Surgical in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, C; Wan, P; Yan, C; Yan, M; Zhu, ZG | 1 |
1 other study(ies) available for imatinib mesylate and Blood Loss, Surgical
| Article | Year |
|---|---|
Choices of surgical approaches for gastrointestinal stromal tumors of the stomach: laparoscopic versus open resection.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Blood Loss, Surgical; Blood Volume; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Laparoscopy; Length of Stay; Male; Middle Aged; Operative Time; Piperazines; Pyrimidines; Stomach Neoplasms; Young Adult | 2012 |